The peripheral blood immune cell composition differed significantly from the immune cell composition in the tumor, with more CD4+ T cells and less CD20+ B cells infiltrating SW480 and HCT116 tumors (Figures 5C, 5D, and S7G). The gene discussed is CD4; the disease is neoplasm.